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Relationship between vitamin B12, folate and
homocysteine levels and H. Pylori infection in
patients with functional dyspepsia: A cross-section
study
Shahid Rasool1, Shahab Abid1, Mohammad Perwaiz Iqbal2*, Naseema Mehboobali2, Ghulam Haider2 and
Wasim Jafri1
Abstract
Background: H. pylori infection has been associated with many micronutrient deficiencies. There is a dearth of data
from communities with nutritional deficiencies and high prevalence of H. pylori infection. The aim of this study was
to determine the impact of H. pylori infection on serum levels of vitamin B12, folate and homocysteine in patients
with functional dyspepsia (FD).
Methods: One hundred and thirty-two patients with FD undergoing gastroscopy were enrolled. The serum was
analyzed for B12, folate and homocysteine levels before gastroscopy. H. pylori infection was diagnosed by
histopathological examination of gastric biopsies and urea breath test. An independent sample t-test and the
Mann–Whitney test were used to compare mean serum concentrations of biomarkers between H. pylori-positive
and H. pylori-negative groups of patients. A Chi-square test was performed to assess the differences among
proportions, while Spearman’s rho was used for correlation analysis between levels of B12 and homocysteine.
Results: The mean age of the group was 40.3 ± 11.5 (19–72) years. Folate deficiency was seen in 43 (34.6%), B12
deficiency in 30 (23.1%) and hyperhomocysteinemia in 60 (46.2%) patients. H. pylori was present in 80 (61.5%) patients
with FD while it was absent in 50 (38.5%). Mean serum levels of B12, folate and homocysteine in the H. pylori-positive
group of patients were not significantly different from the levels in the H. pylori-negative group (357 ± 170 vs. 313 ±
136 pg/mL; p = 0.13), (4.35 ± 1.89 vs. 4.42 ± 1.93 ng/mL; p = 0.84); (15.88 ± 8.97 vs. 16.62 ± 7.82 μmol/L; p = 0.24);
respectively.
B12 deficiency (≤200 pg/mL) was 23.8% in the H. pylori-positive patients versus 22.0% in the H. pylori-negative patients.
Folate deficiency (≤3.5 ng/mL) was 33.8% in the H. pylori-positive group versus 36% in the H. pylori-negative group.
Hyperhomocysteinemia (>15 μmol/L) was present in 46.2% of H. pylori-positive patients compared to 44% in the H.
pylori-negative group. Correlation analysis indicated that serum B12 levels were inversely associated with serum levels of
homocysteine in patients with FD (rho = −0.192; p = 0.028).
Conclusions: This study demonstrated an inverse relationship between serum levels of B12 and homocysteine in
patients with FD. Moreover, no impact of the presence of H. pylori was found on B12, folate and homocysteine levels in
such patients.
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Background
Helicobacter pylorus is a gram negative, microaerophilic
human pathogen which is prevalent worldwide. According
to some community-based studies, more than half of the
adult population in developed countries and 90% of those
in developing countries harbor this bacterium [1,2].
Based on these reports, it is conceivable that the preva-
lence of H. pylori would be very high in the Pakistani
population. Unfortunately, no community-based studies
have been carried out in Pakistan. However, hospital-based
data of dyspeptic patients indicate that the prevalence of
H. pylori in Pakistan is about 80% [3].
H. pylori infection causes gastritis and it is associated
with the development of peptic ulcer disease, gastric car-
cinoma and micronutrient deficiencies [4]. Micronutrient
deficiencies may present with clinical syndromes ranging
from subtle sub-clinical states, dysmotility like dyspepsia or
severe clinical neurological and hematological disorders
[5]. A recent review of a number of published studies on
the influence of H. pylori on nutritional status revealed that
the infection appeared to have a definite negative effect on
vitamin B12 and vitamin C metabolism [6]. In a study from
the Aga Khan University, high prevalence values of vitamin
B12 and folate deficiencies, along with hyperhomocysteine-
mia (>15 μmol/L), were seen in Pakistani patients with
acute myocardial infarction [7]. Hyperhomocysteinemia
and high prevalence of folate deficiency were also observed
in normal healthy subjects [7-9]. FD is a very common
symptom in the community. Whether H. pylori infection
has a role in folate and B12 deficiency in dyspeptic patients
is still controversial.
H. Pylori infection, folate and B12 deficiencies and
hyperhomocysteinemia
H. pylori have been associated with coronary heart disease
[10]. Hyperhomocysteinemia secondary to folate and B12
deficiency might be the link between H. pylori infection
and coronary heart disease. Reduced folate and B12 absorp-
tion can occur in an environment of increased gastric juice
pH. This would result in a reduced folate status leading to
decreased activity of methionine synthase and increased
serum concentration of homocysteine. Homocysteine is
toxic to endothelial cells and a risk factor for atheroscler-
osis [11]. Since 1994, several studies have been published
on B12 and folate levels in H. pylori infected patients with
conflicting results [6,12,13]. A review based upon more
than two dozen studies dealing with H. pylori infection
and vitamin B12 status and H. pylori infection and hyper-
homocysteinemia or both failed to show any clear relation-
ship among H. pylori infection, B12 deficiency and
hyperhomocysteinemia [14]. Hence the objective of this
study was to investigate the relationship between folate,
vitamin B12 and homocysteine levels and the impact of H.
pylori infection on this relationship in patients with FD.
Methods
Study population
One hundred and thirty-two consecutive adult males and
non-pregnant females with symptoms of dyspepsia who
were undergoing gastroscopy were enrolled in the study at
the Aga Khan University Hospital (AKUH) from Jan
2006 - Jan 2008. Prior written informed consent was
obtained from all the study patients. FD was defined as the
presence of one or more symptoms of epigastric pain,
postprandial bloating, epigastric burning and/or early sati-
ety that are considered to originate from the gastroduode-
nal region in the absence of any organic, systemic or
metabolic disease. Before inclusion in the study, patients
were screened for thyroid dysfunction (by determining the
serum levels of triiodothyronine, thyroxine and thyroid
stimulating hormone), gall bladder disease (by ultrasound),
diabetes mellitus (by determining fasting serum levels of
glucose) and hepatitis B and C (by determination of serum
antibodies). Moreover, patients currently using proton
pump inhibitors, strict vegetarians, alcoholics, and other
comorbids like chronic liver disease, chronic renal failure,
and mal- absorption syndrome were excluded from the
study. Patients with a recent history of H. pylori eradica-
tion therapy (during a period of six months prior to the
study) were also excluded. Pregnant females were excluded
due to their physiological state and contraindication of the
urea breath test. Patients with a history of folic acid and
B12 supplementations during the six months prior to the
study were also excluded. A total number of 14 patients
were excluded on the basis of above mentioned criteria. In
the study, we did not include healthy Pakistani adults (as a
negative control group) because 3 studies on healthy
adults in Karachi over the past few years provided us with
sufficient evidence about the prevalence estimates of vita-
min B12 deficiency, folate deficiency and hyperhomocystei-
nemia [7-9]. The study was approved by the Ethics Review
Committee of the Aga Khan University.
Determination of serum levels of vitamin B12, folate and
homocysteine
Prior to the gastroscopy, a fasting venous sample of
5 mL of blood was taken to check serum B12 and folate
and homocysteine levels. Serum samples were analyzed
for folate and vitamin B12 using radio-assays [15,16].
Brief details of these procedures have been given below:
Vitamin B12 (cobalamin) assay:
Vitamin B12 (cobalamin) in serum sample was extracted
by using one volume of serum, one volume of 0.06 M
citrate-phosphate buffer, pH 2.6 and one volume of
KCN (100 μg/mL) in a bath of boiling water for 30 min.
After centrifugation, the clear supernatant solution was
neutralized with 0.2 M Na2HPO4, pH 9.0.
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In this competitive ligand binding assay, [57Co]cyano-
cobalamin [MP Biomedicals, LLC, USA] was used as the
radiolabelled ligand and chicken serum as a binder of vita-
min B12 in a dilution which approximately binds 50% of
the radiolabelled cyanocobalamin. 2.5% hemoglobin-
coated charcoal was used to separate unbound vitamin B12
(labelled as well as unlabelled) from the vitamin bound to
the binder.
A reaction mixture for the standard curve contained
0.7 mL of 0.06 M citrate-phosphate buffer, pH 7.4, con-
taining 70 μg KCN and Ringer’s bicarbonate (110 mM
NaCl, 2 mM NaHCO3, pH 7.4); 0.1 mL [
57Co]cyano-
cobalamin (15 pg); 0.1 mL cyanocobalamin (0-40 pg) or
the unknown sample extract and 0.1 mL of chicken
serum diluted to bind approximately 50% of the radiola-
belled cyanocobalamin. After 30 min incubation at room
temperature in the dark, the reaction was stopped in
each tube by adding 2.5% hemoglobin-coated charcoal
and incubating it at 4⁰C for 5-10 min with intermittent
shaking followed by centrifugation at 3000 rpm for
15 min. Radioactivity in supernatant fraction (1 mL) was
counted in a Gamma Counter (Genesys Gamma 1, La-
boratory Technology Inc., Maple Park, IL, USA). A
standard dose–response curve was generated by plotting
% bound radioactivity versus pg amount of cyanocobala-
min and the concentration of cobalamin in the unknown
sample was determined by reference to this standard
curve. The minimum limit of detection for cobalamin
by this method is 50 pg/mL.
Folate (PteGlu) assay
Folate in the serum was assayed using a noncompetitive
ligand binding radioassay. In this assay, radiolabelled pter-
oylglutamic acid ([3 H] PteGlu; Amersham Pharmacia,
Buckinghamshire, UK) was used as the tracer and methyl-
H4PteGlu (Sigma Chemical Co., St. Louis, MO, USA) as
the unlabelled ligand and β-lactoglobulin (Sigma Chemical
Co., St. Louis, Mo, USA) as the binder. A typical reaction
contained 0.2 mL of 0.05 M borate-Ringer’s buffer, pH 8.0
with ascorbic acid (2 mg/mL); 0.1 mL of methyl-H4PteGlu
(50-300 pg) or 0.02 mL of serum sample and 0.1 mL of β-
lactoglobulin (binder that had been diluted to bind 50-60%
of the tracer used in the assay) in a total reaction volume of
0.4 mL.
The reaction mixture was incubated at room
temperature for 30 min and then the tubes were cooled to
4⁰C by placing them in an ice bath for 30 min. After this
incubation, 0.1 mL of [3 H] PteGlu (200 pg) was added to
each reaction tube and the incubation at 4⁰C was carried
out for another 30 min. Then the reactions were stopped
by adding 0.4 mL of cold 2.5% hemoglobin-coated char-
coal. After thorough mixing, each reaction tube was sub-
jected to centrifugation at 3000 rpm for 10 min at 4⁰C to
pellet the charcoal. Radioactivity in the supernatant
solution (0.5 mL) was counted in LS-6500 Spectrometer
(Beckman Instruments, Palo Alto, CA, USA) using 5 mL
of 3a70 scintillation fluor (Research Product International,
USA). The standard dose–response curve was constructed
by plotting the ratio of % [3 H] PteGlu bound (B) to % [3 H]
PteGlu free (F) as a function of the amount of methyl-
H4PteGlu in each standard. A blank consisting of 0.4 mL
of 0.05 M borate-Ringer’s buffer, pH 8.0 with ascorbic acid
and 0.1 mL of [3 H] PteGlu (200 pg) was also run to find
out the radioactivity other than [3 H] PteGlu in the tracer.
These counts were subtracted from each reaction. Con-
centration of methyl-H4PteGlu in the test sample was
determined by reference to this standard dose–response
curve. The minimum limit of detection for methyl-
H4PteGlu by this method is 0.5 ng/mL.
Both the assay methods were validated by “recovery
studies”. A known amount of cyanocobalamin or methyl-
H4PteGlu was added to the human serum sample. Using
the assay for cobalamin or folate, recovery of added vita-
min was determined in the sample. For quality assurance
in every assay, standard control serum samples obtained
from Aga Khan University Hospital Clinical Laboratory
containing the vitamin in low and high concentrations
(relative to the normal range of levels of that vitamin)
were run along with the standard curve. If the inter-assay
variation in concentration of these controls was greater
than 15%, the samples along with the standard curve
were repeated.
Serum samples were screened for homocysteine using a
kit method based on fluorescence polarization immuno-
assay (Abbott Laboratories, Ltd., Pakistan) following the
manufacturer’s instructions. The minimum limit of detec-
tion for homocysteine by this assay is 4 μmol/L.
Assessment of H. Pylori infection
In this study, H. pylori infection was defined by the dem-
onstration of this bacterium on biopsies by two staining
methods and positive [14 C] urea breath test [17].
Two biopsy samples were taken from the antrum and
body of the stomach using a standard biopsy forceps for
histopathological examination. These biopsy specimens
were stained with Hematoxylin & Eosin and Giemsa
stain for the detection of H. pylori. This is an established
method for the detection of H. pylori [17]. After gastros-
copy, [14 C] urea breath test (UBT) was performed for the
rapid diagnosis of H. pylori infection. Microdose [14 C]
UBT is claimed to be a reliable and rapid diagnostic test
for H. pylori infection and it has been validated by several
studies [18]. Patients positive with both methods were
regarded as true positive, while those negative with both
methods were regarded as true negative. If only one result
was positive, that patient was excluded from the study.
The serum levels were dichotomized to separate vari-
ables to reflect the status, as vitamin B12 deficiency
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(≤200 pg/mL), folate deficiency (≤3.5 ng/mL) and hyper-
homocysteinemia (>15 μmol/L). Patients were divided
into two groups on the basis of the presence of H. pylori
infection.
Statistical analysis
The results are presented as means ± standard deviation,
median with interquartile range (IQR) for most of the con-
tinuous variables and number (percentages) for categorical
variables. Univariate analysis was performed by using a chi-
square test to assess the difference among the proportions.
An independent sample t-test was used to compare the dif-
ference of means if the independent variables followed nor-
mal distribution, otherwise the Mann–Whitney U-test
(non-parametric) was performed for H. pylori positive and
negative groups. Spearman’s rho was used for correlation
analysis between vitamin B12 levels or folate levels and
homocysteine concentration. A p-value< 0.05 was consid-
ered as statistically significant. All p-values were two sided.
The Statistical Package for Social Science SPSS (Release
11.5.0, standard version, copyright© SPSS; 1989-2002) was
used for data analysis.
Results
A total of one hundred and thirty two patients (85 males
and 47 females) fulfilling the inclusion criteria were en-
rolled in the study. The mean age of the study group was
40.3 ± 11.5 years (range 19–72 years). H. pylori was present
in 81 (61.4%) patients, while it was absent in 51 (38.6%).
There were no significant differences in age and gender of
H. pylori positive and negative patients. Complete bio-
chemical data were available for 130 patients. Analysis of
these data revealed that serum levels of vitamin B12, folate
and homocysteine were not significantly different between
H. pylori positive and H. pylori negative patients (Table 1).
The mean serum concentration of total homocysteine in
male patients was significantly higher than that of female
patients (17.3 ± 9 vs. 14 ± 7.2 μmol/L; p = 0.02). However,
in H. pylori positive patients a statistically significant differ-
ence was observed in homocysteine concentrations be-
tween males and females (p = 0.008; Table 2). Correlation
analysis of total homocysteine concentration vs. age indi-
cated no significant relationship (p = 0.77).
Percent deficiencies of B12 and folate in patients with FD
were found to be 23.1% and 34.6%, respectively. However,
no difference was found between the proportions of the
deficiencies of these two vitamins in H. pylori positive and
H. pylori negative patients (p> 0.05; Table 3).
Hyperhomocysteinemia was present in 46.2% of all
patients. However, in patients with H. pylori infection,
hyperhomocysteinemia was found in 37 (46.2%) of them
as compared to 22 (44%) in the H. pylori negative group
(p = 0.82). Correlation analysis (Spearman’s rho) indicated
that serum B12 levels were inversely correlated with serum
homocysteine in these patients with FD (rho = −0.192; p =
0.028). No statistically significant relationship between fol-
ate and/or B12 deficiency and serum levels of homocyst-
eine was observed between the H. pylori positive and H.
pylori negative patients (Table 4).
Discussion
B12 deficiency had been reported to be 6.6% and 9.7% in
the normal healthy adult population of Pakistan, which is
mostly non-vegetarian [7-9]. Compared to this, there
Table 1 Vitamin B12, folate and homocysteine levels in H. pylori-positive and negative patients with functional
dyspepsia
Variable Concentration P value*
H. pylori positive H. pylori negative
(n = 80) (n = 50)
Mean ± SD/median (IQR) Mean ± SD/median (IQR)
Vitamin B12 (pg/mL) 357 ± 170/350 (240) 313 ± 136/290 (170) 0.13
Folate (ng/mL) 4.35 ± 1.89/4.6 (2.85) 4.42 ± 1.93/4.5 (3.32) 0.84
Homocysteine (μmol/L) 15.88 ± 8.97/13.84 (8.97) 16.62 ± 7.82/14.5 (7.62) 0.24
*The Mann–Whitney test was used to compare mean homocysteine levels in H. pylori positive vs. H. pylori negative groups, while an independent sample t test
was used for comparison of mean concentrations of vitamin B12 and folate between H. pylori positive and H. pylori negative groups.
Table 2 Gender difference in homocysteine levels in patients with functional dyspepsia with and without H. pylori
infection
Patient group Homocysteine concentration (μmol/L) P value*
n Males n Females
Mean ± SD/median (IQR) Mean ± SD/median (IQR)
H. pylori positive (n = 80) 52 17.1 ± 9.43/15.4 (9.0) 28 13.58 ± 7.7/11.7 (7.94) 0.008
H. pylori negative (n = 50) 32 17.7 ± 8.4/15.2 (7.0) 18 14.8 ± 6.4/12.8 (9.42) 0.09
*The Mann–Whitney test was used to compare homocysteine levels in males and females in each group of patients.
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was a high proportion of B12 deficiency (23.1%) in our
patients with FD. Other studies from Pakistan and neigh-
boring countries have also shown a high prevalence of
B12 deficiency in the apparently healthy population
[19,20]. Only two studies in Asia have been conducted
which demonstrate B12 deficiency in patients with upper
gastrointestinal symptoms [21,22]. These two studies
attributed B12 deficiency to H. pylori infection. However,
our results did not show similar involvement in Pakistani
patients with dyspepsia.
Very high levels of homocysteine have been previously
reported in healthy adult populations in Pakistan and
neighboring India [8,9,19,23,24] with nutritional defi-
ciency and lead pollution being possibly the major deter-
minants. In the present study, hyperhomocysteinemia
was found in 46.2% of patients with FD. This is a higher
proportion as compared to 32% in an apparently healthy
population study conducted in Karachi, Pakistan [8].
The role of H. pylori infection in micronutrient deficien-
cies is still not clear. The association of H. pylori infection
and food cobalamin malabsorption has suggested to many
investigators that H. pylori infection may predispose or
even be causative in B12 deficiency [21,25,26]. H. pylori can
cause B12 malabsorption by hypochlorhydria associated
with atrophic gastritis which may lead to a failure in the
splitting of B12 from food binders and its subsequent
transfer to salivary R-binder in the stomach [6]. Another
study demonstrated a decreased secretion of ascorbic acid
from gastric mucosa and inactivation of intrinsic factor,
and possibly leading to a decrease in B12 and folate absorp-
tion in patients who are harboring H. pylori infection. The
ensuing deficiency of B12 and folate in such patients would
lead to hyperhomocysteinemia [6,27].
Conflicting studies exist in the literature related to the
effect of H.pylori eradication on serum B12 levels. Some
of these have shown an improvement in vitamin B12 level
after successful eradication of H. pylori infection or a
positive association [13,28,29], while other found no rela-
tion between H. pylori infection and B12 deficiency [12].
Similarly, conflicting results have been reported regard-
ing the effect of H. pylori on serum folate and homocyst-
eine levels. Serum levels of folate were found to be
significantly low and homocysteine levels significantly
high in an H. pylori infected group of patients undergo-
ing coronary arteriography [13]. In the present study, no
differences were found in the concentrations of serum
folate as well as homocysteine in H. pylori positive and
H. pylori negative patients with FD. Our observations are
supported by other studies demonstrating no clear asso-
ciation between H. pylori infection and serum folate and
homocysteine levels [30-32].
Conclusion
The present study demonstrated an inverse relationship
between serum levels of vitamin B12 and homocysteine
in patients with FD. Moreover, no impact of the presence
of H. pylori was found on B12, folate and homocysteine
levels in such patients.
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Table 3 Hyperhomocysteinemia, B12 and folate
deficiencies in patients with functional dyspepsia with or
without H.pylori infection
Parameter H. pylori positive H. pylori negative
(n = 80) (n = 50)
n (%) n (%)
Vitamin B12 deficiency 19 (23.8) 11 (22)
(≤200 pg/mL)
Folate deficiency 27 (33.8) 18 (36)
(≤3.5 ng/mL)
Hyperhomocysteinemia 37 (46.2) 22 (44)
(>15 μmol/L)
Percentages in H. pylori positive and H. pylori negative patients were compared
by employing a test of association using chi-square.
Table 4 Relationships between B12, folate and homocysteine levels with H. pylori status in functional dyspepsia
patients
Vitamin status H. pylori positive (n = 80) H. pylori negative (n = 50)
P value*
n Homocysteine (μmol/L) P value* n Homocysteine (μmol/L)
Mean ± SD/median (IQR) Mean ± SD/median (IQR)
Vit B12 deficient (≤200 pg/mL) 19 15.8 ± 7.3/15.5 (9.2) 0.68 11 18.1 ± 7.9/16.2 (7.0) 0.33
Vit B12 normal (>200 pg/mL) 61 15.9 ± 9.5/13.8 (8.2) 39 16.2 ± 7.9/14.2 (9.1)
Folate deficient (≤3.5 ng/mL) 27 17.4 ± 7.7/15.3 (11.9) 0.07 18 19.6 ± 10.5/17.2 (8.9) 0.16
Folate normal (>3.5 ng/mL) 53 15.1 ± 9.5/13.1 (7.6) 32 14.9 ± 5.3/13.9 (5.8)
*The Mann–Whitney test was used to compare mean homocysteine levels in vitamin deficient vs. vitamin normal groups.
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